CN109527313A - A kind of functional beverage and preparation method thereof can be relieved vision and physical fatigue - Google Patents
A kind of functional beverage and preparation method thereof can be relieved vision and physical fatigue Download PDFInfo
- Publication number
- CN109527313A CN109527313A CN201811554191.0A CN201811554191A CN109527313A CN 109527313 A CN109527313 A CN 109527313A CN 201811554191 A CN201811554191 A CN 201811554191A CN 109527313 A CN109527313 A CN 109527313A
- Authority
- CN
- China
- Prior art keywords
- parts
- acid
- relieved
- vision
- physical fatigue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004438 eyesight Effects 0.000 title claims abstract description 46
- 235000020510 functional beverage Nutrition 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 34
- 150000001413 amino acids Chemical class 0.000 claims abstract description 21
- 239000011782 vitamin Substances 0.000 claims abstract description 21
- 229940088594 vitamin Drugs 0.000 claims abstract description 20
- 229930003231 vitamin Natural products 0.000 claims abstract description 20
- 235000013343 vitamin Nutrition 0.000 claims abstract description 20
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 19
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 18
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 18
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 17
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 15
- 239000002773 nucleotide Substances 0.000 claims abstract description 14
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 14
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 13
- 235000010755 mineral Nutrition 0.000 claims abstract description 13
- 239000011707 mineral Substances 0.000 claims abstract description 13
- 239000005018 casein Substances 0.000 claims abstract description 11
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 235000021240 caseins Nutrition 0.000 claims abstract description 11
- 229930014669 anthocyanidin Natural products 0.000 claims abstract description 10
- 150000001452 anthocyanidin derivatives Chemical class 0.000 claims abstract description 10
- 235000008758 anthocyanidins Nutrition 0.000 claims abstract description 10
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 9
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 9
- 229960000367 inositol Drugs 0.000 claims abstract description 9
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 9
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims abstract description 8
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 8
- 240000003553 Leptospermum scoparium Species 0.000 claims abstract description 8
- 108010001441 Phosphopeptides Proteins 0.000 claims abstract description 8
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 8
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 8
- 229960001948 caffeine Drugs 0.000 claims abstract description 8
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000008101 lactose Substances 0.000 claims abstract description 8
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims abstract description 8
- 239000011746 zinc citrate Substances 0.000 claims abstract description 8
- 235000006076 zinc citrate Nutrition 0.000 claims abstract description 8
- 229940068475 zinc citrate Drugs 0.000 claims abstract description 8
- WHGYBXFWUBPSRW-UHFFFAOYSA-N Cycloheptaamylose Natural products O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO WHGYBXFWUBPSRW-UHFFFAOYSA-N 0.000 claims abstract description 7
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 7
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 7
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 7
- 239000012141 concentrate Substances 0.000 claims abstract description 7
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims abstract description 7
- 229940105902 mint extract Drugs 0.000 claims abstract description 7
- 235000021119 whey protein Nutrition 0.000 claims abstract description 7
- 240000000759 Lepidium meyenii Species 0.000 claims abstract description 6
- 235000000421 Lepidium meyenii Nutrition 0.000 claims abstract description 6
- 235000012902 lepidium meyenii Nutrition 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims description 55
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 46
- 239000002994 raw material Substances 0.000 claims description 38
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 24
- 238000012216 screening Methods 0.000 claims description 23
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 21
- 235000001014 amino acid Nutrition 0.000 claims description 20
- 229940024606 amino acid Drugs 0.000 claims description 20
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 18
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 18
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 16
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 16
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 16
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 15
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 15
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 15
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 15
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 229960003512 nicotinic acid Drugs 0.000 claims description 15
- 230000001954 sterilising effect Effects 0.000 claims description 15
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 14
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 claims description 14
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 14
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 14
- 230000015572 biosynthetic process Effects 0.000 claims description 14
- 239000011734 sodium Substances 0.000 claims description 14
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 13
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 13
- 235000001968 nicotinic acid Nutrition 0.000 claims description 13
- 239000011664 nicotinic acid Substances 0.000 claims description 13
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- 235000002639 sodium chloride Nutrition 0.000 claims description 13
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 12
- 238000011049 filling Methods 0.000 claims description 12
- 229940055726 pantothenic acid Drugs 0.000 claims description 12
- 235000019161 pantothenic acid Nutrition 0.000 claims description 12
- 239000011713 pantothenic acid Substances 0.000 claims description 12
- 238000007873 sieving Methods 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 11
- 108010076119 Caseins Proteins 0.000 claims description 10
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 10
- 235000012680 lutein Nutrition 0.000 claims description 10
- 229960005375 lutein Drugs 0.000 claims description 10
- 239000001656 lutein Substances 0.000 claims description 10
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 10
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 10
- 229960003966 nicotinamide Drugs 0.000 claims description 10
- 235000005152 nicotinamide Nutrition 0.000 claims description 10
- 239000011570 nicotinamide Substances 0.000 claims description 10
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 10
- 102000016938 Catalase Human genes 0.000 claims description 9
- 108010053835 Catalase Proteins 0.000 claims description 9
- 239000004471 Glycine Substances 0.000 claims description 9
- 239000001506 calcium phosphate Substances 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 9
- 229940107700 pyruvic acid Drugs 0.000 claims description 9
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 9
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 9
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 9
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 9
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 9
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 8
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 8
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 8
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 8
- 229960003624 creatine Drugs 0.000 claims description 8
- 239000006046 creatine Substances 0.000 claims description 8
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 8
- 229960000304 folic acid Drugs 0.000 claims description 8
- 235000019152 folic acid Nutrition 0.000 claims description 8
- 239000011724 folic acid Substances 0.000 claims description 8
- 229960002477 riboflavin Drugs 0.000 claims description 8
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 8
- 239000004299 sodium benzoate Substances 0.000 claims description 8
- 235000010234 sodium benzoate Nutrition 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 229960003080 taurine Drugs 0.000 claims description 8
- 239000011787 zinc oxide Substances 0.000 claims description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 7
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 7
- 235000019743 Choline chloride Nutrition 0.000 claims description 7
- 235000005979 Citrus limon Nutrition 0.000 claims description 7
- 244000131522 Citrus pyriformis Species 0.000 claims description 7
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 claims description 7
- 235000000638 D-biotin Nutrition 0.000 claims description 7
- 239000011665 D-biotin Substances 0.000 claims description 7
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 claims description 7
- 239000011627 DL-alpha-tocopherol Substances 0.000 claims description 7
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 7
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 7
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 7
- 239000004472 Lysine Substances 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 7
- 235000003704 aspartic acid Nutrition 0.000 claims description 7
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 7
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 7
- 108010079058 casein hydrolysate Proteins 0.000 claims description 7
- 229960003178 choline chloride Drugs 0.000 claims description 7
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 7
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 7
- KURVIXMFFSNONZ-WFIJOQBCSA-L disodium;[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(=O)NC(=O)C=C1 KURVIXMFFSNONZ-WFIJOQBCSA-L 0.000 claims description 7
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 7
- 235000010350 erythorbic acid Nutrition 0.000 claims description 7
- 239000000787 lecithin Substances 0.000 claims description 7
- 229940067606 lecithin Drugs 0.000 claims description 7
- 235000010445 lecithin Nutrition 0.000 claims description 7
- 229960004488 linolenic acid Drugs 0.000 claims description 7
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 7
- 229940099596 manganese sulfate Drugs 0.000 claims description 7
- 239000011702 manganese sulphate Substances 0.000 claims description 7
- 235000007079 manganese sulphate Nutrition 0.000 claims description 7
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 7
- 239000001103 potassium chloride Substances 0.000 claims description 7
- 235000011164 potassium chloride Nutrition 0.000 claims description 7
- 235000019192 riboflavin Nutrition 0.000 claims description 7
- 239000002151 riboflavin Substances 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- 235000019832 sodium triphosphate Nutrition 0.000 claims description 7
- 238000003860 storage Methods 0.000 claims description 7
- DINKXUCRJBUQAZ-UHFFFAOYSA-N tert-butyl 5-bromopyridine-3-carboxylate Chemical compound CC(C)(C)OC(=O)C1=CN=CC(Br)=C1 DINKXUCRJBUQAZ-UHFFFAOYSA-N 0.000 claims description 7
- 229940026510 theanine Drugs 0.000 claims description 7
- 229960000984 tocofersolan Drugs 0.000 claims description 7
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 7
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 7
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 claims description 6
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims description 6
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 6
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims description 6
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 6
- 239000011706 ferric diphosphate Substances 0.000 claims description 6
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 6
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 6
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 150000002739 metals Chemical class 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 6
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 6
- 229960005055 sodium ascorbate Drugs 0.000 claims description 6
- 239000011781 sodium selenite Substances 0.000 claims description 6
- 235000015921 sodium selenite Nutrition 0.000 claims description 6
- 229960001471 sodium selenite Drugs 0.000 claims description 6
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 6
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 6
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 6
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 6
- 229940061671 uridine 5-mo-phos disod Drugs 0.000 claims description 6
- 235000005282 vitamin D3 Nutrition 0.000 claims description 6
- 239000011647 vitamin D3 Substances 0.000 claims description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 6
- 229940021056 vitamin d3 Drugs 0.000 claims description 6
- 229930010555 Inosine Natural products 0.000 claims description 5
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims description 5
- 229960003786 inosine Drugs 0.000 claims description 5
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 claims description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 4
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 4
- 239000000770 propane-1,2-diol alginate Substances 0.000 claims description 4
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 claims description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 3
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 claims description 3
- WWDMJSSVVPXVSV-YCNIQYBTSA-N retinyl ester Chemical compound CC1CCCC(C)(C)C1\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O WWDMJSSVVPXVSV-YCNIQYBTSA-N 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000002777 nucleoside Substances 0.000 claims description 2
- 125000003835 nucleoside group Chemical group 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 235000013928 guanylic acid Nutrition 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 230000008901 benefit Effects 0.000 abstract description 5
- 206010016256 fatigue Diseases 0.000 description 45
- 235000013305 food Nutrition 0.000 description 31
- 235000013361 beverage Nutrition 0.000 description 22
- 230000006870 function Effects 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 230000004060 metabolic process Effects 0.000 description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 11
- 239000011575 calcium Substances 0.000 description 11
- 229910052791 calcium Inorganic materials 0.000 description 11
- 238000001727 in vivo Methods 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- -1 iron ion Chemical class 0.000 description 9
- 235000000346 sugar Nutrition 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 230000003860 sleep quality Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000013589 supplement Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 208000005374 Poisoning Diseases 0.000 description 7
- 230000034994 death Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 231100000572 poisoning Toxicity 0.000 description 7
- 230000000607 poisoning effect Effects 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 208000003464 asthenopia Diseases 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- 102000001554 Hemoglobins Human genes 0.000 description 4
- 108010054147 Hemoglobins Proteins 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 210000001508 eye Anatomy 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 235000020778 linoleic acid Nutrition 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- UPJKSWLLCONYMW-UHFFFAOYSA-N 5'-Adenosine monophosphate Natural products COc1cc(O)c(C(=O)C)c(OC2OC(COC3OC(C)C(O)C(O)C3O)C(O)C(O)C2O)c1 UPJKSWLLCONYMW-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 3
- 239000000370 acceptor Substances 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 239000000783 alginic acid Substances 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 229960001126 alginic acid Drugs 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000002489 hematologic effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 229960000342 retinol acetate Drugs 0.000 description 3
- 235000019173 retinyl acetate Nutrition 0.000 description 3
- 239000011770 retinyl acetate Substances 0.000 description 3
- 230000009469 supplementation Effects 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 229940046001 vitamin b complex Drugs 0.000 description 3
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010051696 Growth Hormone Proteins 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical class C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 102100038803 Somatotropin Human genes 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003537 Vitamin B3 Natural products 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 150000005693 branched-chain amino acids Chemical class 0.000 description 2
- 210000001736 capillary Anatomy 0.000 description 2
- 229960004203 carnitine Drugs 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 208000007287 cheilitis Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- PVBRXXAAPNGWGE-LGVAUZIVSA-L disodium 5'-guanylate Chemical compound [Na+].[Na+].C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O PVBRXXAAPNGWGE-LGVAUZIVSA-L 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 229940091258 selenium supplement Drugs 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019160 vitamin B3 Nutrition 0.000 description 2
- 239000011708 vitamin B3 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- TZBGSHAFWLGWBO-ABLWVSNPSA-N (2s)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-1h-pteridin-6-yl)methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid Chemical compound C1=CC(C(=O)N[C@@H](CCC(=O)OC)C(O)=O)=CC=C1NCC1NC(C(=O)NC(N)=N2)=C2NC1 TZBGSHAFWLGWBO-ABLWVSNPSA-N 0.000 description 1
- OCUSNPIJIZCRSZ-ZTZWCFDHSA-N (2s)-2-amino-3-methylbutanoic acid;(2s)-2-amino-4-methylpentanoic acid;(2s,3s)-2-amino-3-methylpentanoic acid Chemical compound CC(C)[C@H](N)C(O)=O.CC[C@H](C)[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O OCUSNPIJIZCRSZ-ZTZWCFDHSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 description 1
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GDSOZVZXVXTJMI-SNAWJCMRSA-N (e)-1-methylbut-1-ene-1,2,4-tricarboxylic acid Chemical compound OC(=O)C(/C)=C(C(O)=O)\CCC(O)=O GDSOZVZXVXTJMI-SNAWJCMRSA-N 0.000 description 1
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- WNCAVNGLACHSRZ-KAMYIIQDSA-N Allithiamine Chemical compound C=CCSSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-KAMYIIQDSA-N 0.000 description 1
- WNCAVNGLACHSRZ-UHFFFAOYSA-N Allithiamine Natural products C=CCSSC(CCO)=C(C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-UHFFFAOYSA-N 0.000 description 1
- 206010002064 Anaemia macrocytic Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- AANLCWYVVNBGEE-IDIVVRGQSA-L Disodium inosinate Chemical group [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 AANLCWYVVNBGEE-IDIVVRGQSA-L 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 239000005955 Ferric phosphate Substances 0.000 description 1
- 208000005232 Glossitis Diseases 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000008934 Muscle Proteins Human genes 0.000 description 1
- 108010074084 Muscle Proteins Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102000004879 Racemases and epimerases Human genes 0.000 description 1
- 108090001066 Racemases and epimerases Proteins 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000218636 Thuja Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 208000007642 Vitamin B Deficiency Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047634 Vitamin K deficiency Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- SLIUELDPAPMQIB-IDIVVRGQSA-N [Na].[Na].[C@@H]1([C@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O1)N1C=NC=2C(O)=NC=NC12 Chemical compound [Na].[Na].[C@@H]1([C@H](O)[C@H](O)[C@@H](COP(=O)(O)O)O1)N1C=NC=2C(O)=NC=NC12 SLIUELDPAPMQIB-IDIVVRGQSA-N 0.000 description 1
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 235000013574 canned fruits Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000005471 carotenols Nutrition 0.000 description 1
- 150000001748 carotenols Chemical class 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 1
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 235000013890 disodium inosinate Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 201000008496 endemic goiter Diseases 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229940032958 ferric phosphate Drugs 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000019261 food antioxidant Nutrition 0.000 description 1
- 235000010855 food raising agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000007674 genetic toxicity Effects 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000036734 inhibitory postsynaptic potential Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 235000013902 inosinic acid Nutrition 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- WBJZTOZJJYAKHQ-UHFFFAOYSA-K iron(3+) phosphate Chemical compound [Fe+3].[O-]P([O-])([O-])=O WBJZTOZJJYAKHQ-UHFFFAOYSA-K 0.000 description 1
- 229910000399 iron(III) phosphate Inorganic materials 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 239000011499 joint compound Substances 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000006437 macrocytic anemia Diseases 0.000 description 1
- 208000038015 macular disease Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910001511 metal iodide Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000019175 phylloquinone Nutrition 0.000 description 1
- 239000011772 phylloquinone Substances 0.000 description 1
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229960001898 phytomenadione Drugs 0.000 description 1
- 235000008373 pickled product Nutrition 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 239000011819 refractory material Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000022925 sleep disturbance Diseases 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000012976 tarts Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000021468 vitamin B8 Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a kind of functional beverages that can be relieved vision and physical fatigue, including wolfberry fruit extract 7-15, mint extract 3-4, cornel extractive 1-5, tea tree purple bud anthocyanidin 10-17, lactose 75-125, whey protein concentrate 32-55, caffeine 0.08-0.12, galactooligosaccharide 14-26, maca 0.2-1.5, inositol 19-20, zinc citrate 0.04-0.05, casein phosphopeptide 2-3, cycloheptaamylose 0.01-0.02, regulator 0.3-0.56, antioxidant 0.25-0.58, amino acid 4-7.2, nucleotide 0.25-0.4, vitamin combination 1.562-3.155, minerals 0.32-0.485 and water 1500 - 4500.The utility model has the advantages that fatigue can be effectively relieved, promote antisecosis.
Description
Technical field
The present invention relates to food processing technology fields, it particularly relates to a kind of function that can be relieved vision and physical fatigue
Energy property beverage and preparation method thereof.
Background technique
When people carry out the movement of big intensity, some sweat can be lost, main ingredient is water in sweat, but also containing few
The electrolyte of amount, mainly sodium and chloride ion, there are also a small amount of potassium and calcium, the electrolyte in body is exactly to be lost silently at this moment
's.Just often will appear malaise, asthenopia, it is absent minded situations such as, to influence the working efficiency of people.Physical strength
Fatigue be due to when people for a long time, the physical exertion campaign of intensity greatly when, produce a large amount of metabolin in vivo, in addition,
Visual fatigue is many times all since eyes are dry and astringent, headache, dizzy can not all work.
Current market sales of drinks, these functional beverages are based on quickly regaining one's strength, but its most volume
Be added to a large amount of sugar outside, human body long-term drinking or it is excessive drink can not only take in after above-mentioned beverage a large amount of non-essential elements and
It is easy to cause problem of obesity.How to make functional beverage have both can rapid recovery physical strength and asthenopia can also be used as protecting for a long time
Strong beverage is drunk, and the developing direction of industry is become.
For the problems in the relevant technologies, currently no effective solution has been proposed.
Summary of the invention
For the problems in the relevant technologies, the present invention propose a kind of functional beverage that can be relieved vision and physical fatigue and
Preparation method, to overcome above-mentioned technical problem present in existing the relevant technologies.
For this purpose, the specific technical solution that the present invention uses is as follows:
According to an aspect of the invention, there is provided a kind of functional beverage that can be relieved vision and physical fatigue.
This can be relieved vision and the functional beverage of physical fatigue is made of the raw material of following mass fraction:
7-15 parts of wolfberry fruit extract, 3-4 parts of mint extract, 1-5 parts of cornel extractive, tea tree purple bud anthocyanidin 10-
17 parts, 75-125 parts of lactose, 32-55 parts of whey protein concentrate, 0.08-0.12 parts of caffeine, 14-26 parts of galactooligosaccharide, Ma
0.2-1.5 parts of coffee, 19-20 parts of inositol, 2.8-2.86 parts of linoleic acid, 0.1-0.5 parts of citric acid, 0.1-0.2 parts of essence, α-flax
0.38-0.39 parts sour, 0.1-0.3 parts of sodium citrate, 0.1-0.3 parts of sodium benzoate, 17.5-18.5 parts of caseinhydrolysate, lemon
0.1-0.2 parts yellow, 10-30 parts of docosahexaenoic acid, 0.04-0.05 parts of zinc citrate, 2-3 parts of casein phosphopeptide, lecithin
25-35 parts of rouge, 0.01-0.02 parts of cycloheptaamylose, 0.3-0.56 parts of regulator, 0.25-0.58 parts of antioxidant, amino acid 4-
7.2 parts, 0.25-0.4 parts of nucleotide, 1.562-3.155 parts of vitamin combination, 0.32-0.485 parts of minerals and water 1500-
4500 parts.
Further, the regulator includes following material component: 0.05-0.08 parts of sodium tripolyphosphate, Citric Acid Mono
0.2-0.4 parts and propylene glycol alginate 0.05-0.08 parts.
Further, the antioxidant includes following material component: 0.05-0.25 parts of lutein, D-araboascorbic acid
0.15-0.22 parts of sodium, 0.02-0.04 parts of superoxide dismutase, 0.01-0.03 parts of catalase and pyruvic acid 0.02-
0.04 part.
Further, the amino acid includes following material component: 1-1.2 parts of taurine, 0.4-1.2 parts of creatine, bright ammonia
0.4-0.8 parts sour, 0.3-0.6 parts of glycine, 0.4-0.8 parts of L-carnitine, 0.2-0.4 parts of tyrosine, lysine 0.6-0.8
Part, 0.3-0.6 parts of aspartic acid, 0.2-0.4 parts of theanine and 0.2-0.4 parts of glutamine.
Further, the nucleotide includes following material component: 5 ' 0.05-0.08 parts of adenosine monophosphate, 5 ' inosinicacids
0.05-0.08 parts of disodium, 0.05-0.08 parts of 5 ' Sodium guanylate, 0.05-0.08 parts of 5 ' uridine monophosphate disodium and 5 ' cytidine acid disodiums
0.05-0.08 parts.
Further, the vitamin combination includes following material component: 0.015-0.025 parts of choline chloride, L are anti-bad
0.055-0.085 parts of hematic acid sodium, 0.015-0.025 parts of retinol acetate, 0.025-0.035 parts of D calcium pantothenate, dl- alpha-tocopherol
0.025-0.045 parts, 0.035-0.045 parts of Vitamin D3,0.025-0.045 parts of phytondione and B race composition 1.367-
2.85 part.
Further, B race composition includes following material component: 0.065-0.095 parts of riboflavin, niacinamide
0.025-0.085 parts, 0.012-0.025 parts of D-Biotin, 0.015-0.025 parts of folic acid, 0.045-0.065 parts of niacin, pantothenic acid
1.1-2.4 parts, 0.045-0.065 parts of thiamine hydrochloride, 0.035-0.045 parts of puridoxine hydrochloride and cobalamin 0.025-0.045
Part.
Further, the minerals include following material component: 0.02-0.025 parts of calcium monohydrogen phosphate, tricalcium phosphate
0.02-0.03 parts, 0.06-0.08 parts of magnesium chloride, 0.065-0.095 parts of ferric pyrophosphate, 0.035-0.065 parts of zinc oxide, chlorination
0.015-0.025 parts of sodium, 0.045-0.065 parts of potassium chloride, 0.04-0.06 parts of potassium iodide, 0.01-0.02 parts of manganese sulfate and sub- selenium
Sour sodium 0.01-0.02 parts.
According to another aspect of the present invention, a kind of preparation of functional beverage that can be relieved vision and physical fatigue is provided
Method.
This can be relieved the preparation of the functional beverage of vision and physical fatigue, comprising the following steps:
According to above-mentioned mass fraction, weigh it is described can be relieved the functional beverage of vision and physical fatigue needed for raw material, and
During weighing, all raw materials in addition to the water are injected in same container, raw material is promoted to be mixed, formed preliminary
Mixture;
The initial mixture is continuously stirred, the raw material is sufficiently mixed, formation is sufficiently mixed object;
Sieving screening is carried out to the object that is sufficiently mixed by preconfigured screening machine, promotes described to be sufficiently mixed object
State is pulverulent mixture;
By preconfigured apparatus for separating metals, postsearch screening is carried out to the object that is sufficiently mixed after sieving screening, is formed super
Finely powdered mixt, and obtained superfine powdery mixture is put into storage box store it is spare;
The water handle by preconfigured low-frequency resonance instrument spare;
The superfine powdery mixture and the low-frequency resonance water are sufficiently mixed by preset proportion in advance, stirred
It is even that preliminary mixed liquor is made;
The preliminary mixed liquor is successively centrifuged at a high speed, homogeneous, sterilization treatment, homogeneous mixed liquor is made;
It is handled the homogeneous mixed liquor to obtain drinks by preconfigured low-frequency resonance instrument;
The drinks finished product sealing obtained is filling.
Further, the sterilization treatment uses high temperature sterilization, and temperature is 100-110 DEG C, and sterilizing time is 30-35 points
Kind.
Wherein, material component of the present invention is described below:
Fructus lycii: polysaccharides is a kind of water-soluble polysaccharide, is most important active constituent in fructus lycii, research shows that fructus lycii is more
Sugar, which has, to be promoted immune, anti-aging, antitumor, removing free radical, antifatigue, anti-radiation, liver protection, reproductive function protection and improves
The effects of.
Peppermint: peppermint is Chinese conventional Chinese medicine, and young tender stem tip can make vegetable edible, and herb can be used as medicine again, and cure cold fever laryngalgia,
Headache, conjunctival congestion with ophthalmalgia, myalgia, itchy skin with rubella, the diseases such as measles without adequate eruption are furthermore also effective to carbuncle, subcutaneous ulcer, scabies, tinea, dermatitis rhus.
Fructus Corni: contain the stronger saponin raw sugar of physiological activity, polysaccharide, malic acid, tartaric acid, phenols, resin, tannin etc.
Ingredient.Its sour-puckery flavor has nourishing, stomach invigorating, diuresis, nourishing liver and kidney, replenishing qi and blood and other effects.
Tea tree purple bud anthocyanidin: anthocyanidin is a kind of strong antioxidant, it can protect human body from one kind
Do the damage of the harmful substance of free radical.Different from other antioxidants, cyanine is known as the ability across blood-brain barrier, Ke Yizhi
Connect protection cerebral central nervous system.Anthocyanidin can also enhance blood vessel elasticity, improve the circulatory system and promote the smooth of skin
Degree inhibits inflammation and allergy, improves the flexibility in joint.
The generation of heart disease and stroke is reduced by preventing platelet aggregation caused by stress reaction and smoking;Enhancing is exempted from
Epidemic disease system capability resists carcinogen;With anti-inflammatory efficacy, thus the inflammation including arthritis and swelling can be prevented;
Enhance artery, vein and capillary elasticity;Protect arteries inner wall;Keep the flexibility of orthocytosis to help blood
Red blood cell enhances the blood circulation of whole body, organ and system for body various pieces by tiny capillary
Direct benefit is brought, and enhances cell viability;Relaxation blood vessel is to promote blood flow and anti-upper hypertension;Prevent kidney from releasing
Angiotensin converting enzyme caused by blood pressure increase;Become skin by the inhibition to elastoser and Collagenase
Smooth and high resilience, from inside and outside while preventing the skin injury caused by excessive solarization etc..
Lactose: as the absorption dispersing agent of powdered food pigment, pigment concentration is reduced, is easy to use and reduces storage period
Discoloration make the excipient such as tabletting using the compressible forming feature low with water imbibition.
Whey protein concentrate: it is then dry that soluble powder is made using protein in hyperfiltration technique condensed whey, extensively
For food processing industry.
Caffeine: directly acting on nervous centralis, and thinking is promoted to become quick clear;It can be reduced fatigue;It can promote metabolism;
Liver release hepatic glycogen can be stimulated to increase energy i (in vivo);Promote adrenaline in blood to obviously increase, to accelerate heart rate, increases
Flow is healed, oxygen conveying capacity is improved, promotes tricarboxylic acid cycle smooth, guarantee that energy is constantly replenished.
Galactooligosaccharide: galactooligosaccharide is that the beneficial bacteriums such as Bifidobacterium in human body intestinal canal, Lactobacillus acidophilus are fabulous
Nutrient source and effective proliferation factor can improve the digestion and absorption function of human body intestinal canal, promote intestines peristalsis, mitigate possible
Excessive internal heat symptom promotes intestinal health, promotes growth of probiotics, promotes calcium absorption.
Maca: it is rich in high unit nutrient, there is the function of nourishing and fit keeping function to human body.
Inositol: inositol is widely distributed in animal and plant body, is that animal, the growth factor of microorganism and choline are common
It plays a crucial role to the formation of the neuron and nerve synapse in human brain memory area.
Linoleic acid: due to having the function of reducing cholesterol and blood lipid in blood of human body, it can be used as treatment Atherosclerosis
The raw material of chemical drug object.
Citric acid: because citric acid has the tart flavour of mild frankness, be commonly used to various beverages, carbonated drink, grape wine, candy,
The manufacture of the food such as dessert, biscuit, canned fruit juice, dairy products.The salt of citric acid such as calcium citrate and ironic citrate are certain
Need to add the hardening agent of calcium ion and iron ion in food.The esters of citric acid such as triethyl citrate can make nontoxic plasticising
Agent manufactures food packaging plastic film, is the acid of drink and food industry, preservative.
Essence: the raw material of certain fragrance, it is one of the critical materials in manufacturing process.
Alpha-linolenic acid: alpha-linolenic acid is the basic substance for constituting cell membrane and biological enzyme, plays decisive work to human health
With, alpha-linolenic acid be human health it is required but general lack of being badly in need of a kind of essential nutrients of supplement.
Sodium citrate: it is used as acidity regulator, flavouring agent, stabilizer in food, beverage industry.
Sodium benzoate: it is preferable that sodium benzoate belongs to acidic preservative anti-corrosion effect under acidic environment, is the food being in daily use
Preservative is savored, having prevents the rotten effect turned sour, extended the shelf life, it is widely used in various countries in the world.
Caseinhydrolysate: be mammal including main protein in cow, sheep and people's milk, also known as casein, casein,
Lactic casein.
Lemon yellow: for water-soluble synthetic dyestuff.It is monochromatic kind in bright-coloured bright yellow.It is chiefly used in food, beverage, medicine
The coloring of product, cosmetics, feed, tobacco, toy, packaging material for food etc. is also used for wool, the dyeing of silk and manufacture color
It forms sediment.
Docosahexaenoic acid: being commonly called as docosapentaenoic acid, is a kind of pair of very important unsaturated fatty acid of human body, and DHA is mind
A kind of main component for growing and maintaining through system cells, is the important composition ingredient of brain and retina.
Zinc citrate: it is mainly used for food, solid beverage, dairy products, infant food, salt, toothpaste, health care product etc..
Casein phosphopeptide: promoting absorption of the small intestine to calcium, promotes utilization of the bone to calcium, promotes tooth to the benefit of calcium
With.
Lecithin: making cerebral nerve obtain nutritional supplementation in time, is conducive to eliminate fatigue, alleviate nervous.
Cycloheptaamylose: as stabilizer, processing aid etc..
Sodium tripolyphosphate: being usually used in food, makees water retention agent, quality improver, PH regulator, metal-chelator.
Citric Acid Mono: it is mainly used for food, beverage industry as acid, flavoring agent and preservative, antistaling agent.
Propylene glycol alginate: it is often used as the thickening of beverage products, stabilization, emulsifier.
Lutein: natural carotenol is a kind of excellent antioxidant, can resist free radical caused in human body cell with
Organ damage, cardiovascula arteriosclerosis, coronary heart disease and the neoplastic disease etc. for thus preventing body aging to cause.Lutein and zeaxanthin
It is only 2 Carotenoids in eyes, prevents visual impairment caused by senile eyeball retina macular disease and lose
Bright is the unique function of lutein.
D-araboascorbic acid sodium: being a kind of new bio type food antioxidant, anti-corrosive fresh-keeping assistant toner.It can prevent in pickled product
The formation of carcinogen-nitrosamine, eradicates the bad phenomenons such as discoloration, peculiar smell and the muddiness of food and drink.
Superoxide dismutase: a kind of active material derived from life entity can eliminate organism in metabolic processes
The harmful substance of generation constantly supplements human body the special-effect that SOD has anti-aging.
Catalase: catalase be used to remove the peroxide in the milk for manufacturing cheese in the food industry
Change hydrogen, catalase is also used for food packaging, food is prevented to be oxidized.
Pyruvic acid: pyruvic acid can be realized mutual between sugar, fat and amino acid in vivo by acetyl-COA and tricarboxylic acid cycle
Conversion, therefore, pyruvic acid play important pivotal role in the metabolism connection of three major nutrient.
Taurine: body is improved to the utilization rate of protein, promotes the development of brain cell structure and function, taurine is straight
It connects and participates in nerve cell macromolecular anabolism, promote brain nervous cell proliferation, differentiation, to infant's brain development, nerve
Conduction, perfect, calcium the absorption of visual function have good action.
Creatine: creatine supplementation can effectively improve muscular strength, speed and endurance.Physical efficiency and the level of training are improved, is prevented tired
Labor.
Leucine: the effect of leucine includes cooperating to repair muscle together with isoleucine and valine, controls blood glucose, and
Energy is provided to bodily tissue.Leucine, isoleucine and valine are all branched-chain amino acids, after they peomote training
Muscle recovery.Wherein leucine is a kind of most effective branched-chain amino acid, and muscle loss can be effectively prevented, because it can
Faster decomposition and inversion is glucose.
Glycine: in central nervous system, especially in vertebra, glycine is an inhibitory neurotransmitter.If
Glycine recipient is activated, and chloride ion, which enters nerve cell by ion acceptor, leads to inhibitory postsynaptic potential.
L-carnitine: assisting baby to maintain normal body temperature, guarantees the energy supply derived from fat, and prevention baby's carnitine lacks
Disease.
Tyrosine: the raw material of amino acid transfusion and amino acid composite preparation makees nutritional supplement.For treating gray nucleus
The diseases such as scorching and tuberculous encephalitis/hyperthyroidism.
Lysine: belong to one of important component and essential amino acid of protein, adjustable body metabolism
Balance;The absorption and accumulation in vivo that calcium can be improved, accelerate bone growth;There is enhancing development, increases appetite, reduces
Disease and constitutional effect.
Aspartic acid: the inorganic ions such as amino acid transfusion, potassium, calcium replenishers, fatigue recovery agent, ammonia detoxicant, clinic are examined
Off-drug;Treat chronic hepatitis, myocardial metabolism obstacle, low potassium or ischemia anemi;The raw material of novel sweetener aspartame;Battalion
Enriching substance is supported, various cold drinks are made an addition to.
Theanine: having a hypnosis, but can solution disappear fatigue, reduce blood pressure and improve ability of learning and memory.
Glutamine: appropriately supplement glutamine can be effectively prevented the decomposition of muscle protein in time, and can be by thin
The aquation of born of the same parents increases the volume of cell, and muscle is promoted to increase.Glutamine or a few growth hormone can be promoted to release
One of amino acid put.Studies have shown that oral 2 grams of glutamine can make the horizontal of growth hormone improve 4 times, make insulin and
Testosterone secretion increases, to enhance the synthesis of muscle.
5'-monophosphate adenosine: also known as a phosphorus adenylate, a kind of nucleotide found in ribonucleic acid are a kind of phosphoric acid
And the ester of nucleosides adenosine, and by phosphate functional group, pentose nucleic acid sugar and bases adenine is formed and vitamin B8, one
Kind water soluble vitamin.
5'-inosinic acid disodium: being colourless to white crystals or white crystalline powder, to protect it from the food such as flesh of fish
The decomposition of phosphate and its is made to play maximum flavor power in product.
5'-GMP2Na: being colourless to white crystals or white crystalline powder, and delicate flavour intensity is Sodium Inosinate
It is 2.3 times, non-hygroscopic with sodium glutamate and with there is very strong synergistic effect, it is dissolved in water, stabilized aqueous solution.
5'-UMP disodium: for white or off-white powder, production nucleic acid drug intermediate, health food be can be used as
And biochemical reagents.
5'-CMP disodium: flavoring agent, also for supplementing the nucleotide in cow's milk, to produce the breast milk close to human milk
Milk can enhance baby to the resistivity of bacteriosis.
Choline chloride: liver, the Fat Accumulation in kidney and its tissue degeneratiaon can be prevented;It can promote the group again of amino acid
It closes;Amino acid, the especially utilization rate of essential amino acid methionine in vivo can be improved.
L sodium ascorbate: being pharmaceutically used for replenishing vitamins C, and making an addition in food and beverage can be used for anti-oxidant, can have
Effect prevents food and beverage from changing colour, spoiled.
Retinol acetate:: i.e. axerophtholum aceticum is able to maintain that human homergy, be able to maintain that cell membrane stabilization and
Development, the normal function for maintaining reproductive system.
D calcium pantothenate: for medicine, food and feed additive, be the ingredient of coacetylase, participate in carbohydrate, fat and
The metabolism of protein, is clinically used for treatment Vitamin B deficiency disease, peripheral neuritis, and postoperative intestine colic pain participates in albumen
Matter, fat, the metabolism of sugar in vivo.
Dl- alpha-tocopherol: the hydrolysate of vitamin E is one of most important antioxidant.
Vitamin D3: also known as vitamine D3 or cholecalciferol, are one kind of vitamin D, are a kind of fat-soluble dimension lifes
Element is also regarded as a kind of hormone precursor for acting on Ca,P metabolism.
Phytondione: also known as vitamin K1 belongs to a kind of polycyclic aromatic ketone, is a kind of liposoluble vitamin, to sky
Gas and humidity are stablized, but can be decomposed in the sun, belong to vitamin medicaments, caused by being mainly used for various vitamin K deficiencies
The treatment of hemorrhagic disease.
Riboflavin: being called vitamin B2, be internal yellow enzymes prothetic group component part (yellow enzyme is sent out in biological oxidation
Wave and pass hydrogen effect), when lacking, the biological oxidation of body is just influenced, makes metabolism that obstacle occur.Its lesion shows as mouth, eye more
With the inflammation at external genital organs position, such as angular stomatitis, cheilitis, glossitis, eye conjunctivitis and scrotitis.
Niacinamide: niacinamide is a member in vitamin B complex, vitamin B3, and niacin can in vivo be converted into cigarette
Amide.
D-Biotin: also known as biotin, biotin are water soluble vitamins, also belong to vitamin B complex, B7, it is synthesis
Ascorbic necessary material is fat and the indispensable substance of protein eubolism, is that a kind of maintenance human body natural is raw
Long, development and the necessary nutrient of normal human's functional health.
Folic acid: one of vitamin B complex plays the role of promoting juvenile cell in marrow mature, and the mankind can as lacked folic acid
Cause macrocytic anemia and leukopenia, is even more important to pregnant woman.
Niacin: niacin is also referred to as vitamin B3, niacin also known as niacin, antipellagra factor, further includes it in human body
Derivative niacinamide or niacinamide, it is one of 13 kinds of vitamin needed by human, is a kind of water soluble vitamin.
Pantothenic acid: also referred to as vitamin B5, pantothenic acid, odorless, mildly bitter flavor are stored in a variety of foods because of its property slant acidity and extensively
In object, so gain the name.The nutritional status of generally accepted pantothenic acid and hair, skin is closely related, when hair lacks gloss or becomes
It is supplement its visible effect of pantothenic acid when sparse more;Manufacturing antibody is also one of effect of pantothenic acid, and human body can be helped to resist infectious disease,
Multiple Classes of Antibiotics side effect and toxicity are mitigated, allergic symptom is mitigated, pantothenic acid shortage easily causes blood and skin abnormality, generates low blood
The diseases such as sugar
Thiamine hydrochloride: being the hydrochloride of thiamines, is a kind of existence form of vitamin B1, nutritional supplement, vitamin
B1 participates in the intermediate supersession of carbohydrate in vivo.
Puridoxine hydrochloride: vitamin B6, crystallization or the crystalline powder of white or off-white color, odorless, sour hardship, dimension are called
Raw element hardening agent, this product is many enzymes such as glutamic-pyruvic transaminase, decarboxylase, racemase, dehydrogenase, synzyme and hydroxylase etc. in body
Coenzyme, and the decomposition of carbohydrate and protein can be helped, utilized, there is the deficiency disease of similar niacin in when shortage, furthermore vitamin B6
Also participate in the reaction that tryptophan converts niacin to serotonin.And the growth of leucocyte can be stimulated, it is to form hemoglobin institute
The substance needed.
Cobalamin: vitamin B12 participates in the synthesis of methionine, thymidine etc. as the co-factor of transmethylase,
Such as methyl tetrahydrofolate is made to be changed into tetrahydrofolic acid and methyl is transferred to acceptors, keeps acceptors derivative as methyl
Object.
Calcium monohydrogen phosphate: making hardening agent (supplement calcium) and leavening agent, also can be used as quality improver, for Flour product of fermenting,
Appropriate use is needed by production, as food feed additive, to supplement the phosphorus in poultry and livestock feed, calcium constituent.
Tricalcium phosphate: tricalcium phosphate is a kind of safe nutrition fortifier, and the intake of calcium is strengthened in main addition in food,
It can also be used for preventing or treating the symptom of calcium deficiency.Tricalcium phosphate is alternatively arranged as anticaking agent in food, pH value adjustment agent simultaneously,
Buffer etc..
Magnesium chloride: food additives, protein coagulation agent, deicing salt, refrigerant, dust-proofing agent, refractory material etc. can be done.
Ferric pyrophosphate: making nutritional supplement (irony hardening agent) for food industry, be used for strengthening model, baby food and
Other normal foods.
Zinc oxide: zinc oxide has application, including plastics, ceramics, glass, water in multiple material and product as additive
Mud, lubricant, paint, ointment, adhesive, sealant, pigment, food (zinc supplementation agent), battery, Ferrite Material, fire-retardant material
Material and first-aid bandage etc..
Sodium chloride: sodium chloride is that people institute is indispensable, and the physiological function of sodium ion and chloride ion mainly has: maintaining cell
The osmotic pressure of external solution participates in the adjusting of internal acid-base balance, and chloride ion participates in the generation of gastric acid in vivo, in addition, sodium chloride exists
Maintain also have effect in the normal excitability of nerves and muscles.
Potassium chloride: in food service industry, it can be used as salt substitute applied to agricultural production, aquatic products, livestock products, fermentation, seasoning, tank
Head, instant food etc. make low Na prod, to reduce the excessively high adverse effect to body of sodium content.
Potassium iodide: in medicine for preventing and treating endemicgoiter, promote the absorption and eliminating the phlegm of vitreum muddiness, use
Make the cosolvent of photosensitive emulsifier, food additives, iodine and certain insoluble metal iodide.
Manganese sulfate: being the microelement that the crop of synthetic fatty acid needs.
Sodium selenite: selenium is the component part of glutathione peroxidase, and the function of cell membrane is maintained by oxidation,
The yield for improving the endogenous antioxidant of the lipid nature of protein, participates in the conversion of energy, influences to be metabolized, to the cream of fat
Change, absorption and multivitamin absorption play an important role, while also participating in the synthesis with coacetylase, ubiquinone, shadow
The function of ringing other biological enzyme system, all has an impact to the metabolism of amino acid, the synthesis of protein, carbohydate metabolism, biological oxidation.
The invention has the benefit that
(1), the functional beverage provided by the invention that can be relieved vision and physical fatigue while effective using each raw material
Ingredient makes it complement each other, and greatly improves the effect of beverage alleviates physical fatigue and asthenopia, while having both excellent guarantor
Strong performance.The dispersion performance of each component is substantially increased, and effectively reduces the loss of wherein nutritional ingredient, makes the beverage being prepared into
Finished product stability is high, is conducive to large-scale industrial production.
(2), the functional beverage provided by the invention that can be relieved vision and physical fatigue is scientifically above-mentioned various effects
Ingredient incorporates products, these ingredients cooperate, and synergistic effect can promote human metabolism, absorbs and decomposes sugar
Point, a large amount of energy matter is supplemented rapidly, and adjust nervous function, refresh the mind, regain one's strength of body, is antifatigue to obtain
Superior efficacy.Therefore, people is when physiologic fatigability, energy i (in vivo) material want, and energetic supersession is insufficient or there are obstacle, drinks
With the drinks, energy can be sufficiently supplemented, fatigue is quickly eliminated, inspires enthusiasm, improves working efficiency and quality of life.
(3), the functional beverage provided by the invention that can be relieved vision and physical fatigue is in a large amount of movements or weight physical strength
It is drunk after labour or next day match is drunk before sleeping, fatigue can be effectively relieved, improve sleep quality;Spleen benefiting and stimulating the appetite helps
Digestion;It can be improved heart blood supply function simultaneously;Each raw material mutually acts synergistically, and promotes antisecosis.
Detailed description of the invention
It in order to more clearly explain the embodiment of the invention or the technical proposal in the existing technology, below will be to institute in embodiment
Attached drawing to be used is needed to be briefly described, it should be apparent that, the accompanying drawings in the following description is only some implementations of the invention
Example, for those of ordinary skill in the art, without creative efforts, can also obtain according to these attached drawings
Obtain other attached drawings.
Fig. 1 is a kind of preparation method of functional beverage that can be relieved vision and physical fatigue according to an embodiment of the present invention
Flow chart.
Specific embodiment
To further illustrate that each embodiment, the present invention are provided with attached drawing, these attached drawings are that the invention discloses one of content
Point, mainly to illustrate embodiment, and the associated description of specification can be cooperated to explain the operation principles of embodiment, cooperation ginseng
Examine these contents, those of ordinary skill in the art will be understood that other possible embodiments and advantages of the present invention, in figure
Component be not necessarily to scale, and similar component symbol is conventionally used to indicate similar component.
According to an embodiment of the invention, providing a kind of functional beverage that can be relieved vision and physical fatigue.
The functional beverage according to an embodiment of the present invention that can be relieved vision and physical fatigue, this can be relieved vision and physical strength
The functional beverage of fatigue is made of the raw material of following mass fraction:
7-15 parts of wolfberry fruit extract, 3-4 parts of mint extract, 1-5 parts of cornel extractive, tea tree purple bud anthocyanidin 10-
17 parts, 75-125 parts of lactose, 32-55 parts of whey protein concentrate, 0.08-0.12 parts of caffeine, 14-26 parts of galactooligosaccharide, Ma
0.2-1.5 parts of coffee, 19-20 parts of inositol, 2.8-2.86 parts of linoleic acid, 0.1-0.5 parts of citric acid, 0.1-0.2 parts of essence, α-flax
0.38-0.39 parts sour, 0.1-0.3 parts of sodium citrate, 0.1-0.3 parts of sodium benzoate, 17.5-18.5 parts of caseinhydrolysate, lemon
0.1-0.2 parts yellow, 10-30 parts of docosahexaenoic acid, 0.04-0.05 parts of zinc citrate, 2-3 parts of casein phosphopeptide, lecithin
25-35 parts of rouge, 0.01-0.02 parts of cycloheptaamylose, 0.3-0.56 parts of regulator, 0.25-0.58 parts of antioxidant, amino acid 4-
7.2 parts, 0.25-0.4 parts of nucleotide, 1.562-3.155 parts of vitamin combination, 0.32-0.485 parts of minerals and water 1500-
4500 parts.
Wherein, the regulator includes following material component: 0.05-0.08 parts of sodium tripolyphosphate, Citric Acid Mono 0.2-
0.4 part and propylene glycol alginate 0.05-0.08 parts.
The antioxidant includes following material component: 0.05-0.25 parts of lutein, D-araboascorbic acid sodium 0.15-
0.22 part, 0.02-0.04 parts of superoxide dismutase, 0.01-0.03 parts of catalase and 0.02-0.04 parts of pyruvic acid.
The amino acid includes following material component: 1-1.2 parts of taurine, 0.4-1.2 parts of creatine, leucine 0.4-0.8
Part, 0.3-0.6 parts of glycine, 0.4-0.8 parts of L-carnitine, 0.2-0.4 parts of tyrosine, 0.6-0.8 parts of lysine, aspartic acid
0.3-0.6 parts, 0.2-0.4 parts of theanine and 0.2-0.4 parts of glutamine.
The nucleotide includes following material component: 5 ' 0.05-0.08 parts of adenosine monophosphate, 5 ' inosine acid disodium 0.05-
0.08 part, 0.05-0.08 parts of 5 ' Sodium guanylate, 0.05-0.08 parts of 5 ' uridine monophosphate disodium and 5 ' cytidine acid disodium 0.05-0.08
Part.
The vitamin combination includes following material component: 0.015-0.025 parts of choline chloride, L sodium ascorbate
0.055-0.085 parts, 0.015-0.025 parts of retinol acetate, 0.025-0.035 parts of D calcium pantothenate, dl- alpha-tocopherol 0.025-
Composition 1.367-2.85 parts of 0.045 part, 0.035-0.045 parts of Vitamin D3,0.025-0.045 parts of phytondione and B race.
B race composition includes following material component: 0.065-0.095 parts of riboflavin, niacinamide 0.025-0.085
Part, 0.012-0.025 parts of D-Biotin, 0.015-0.025 parts of folic acid, 0.045-0.065 parts of niacin, 1.1-2.4 parts of pantothenic acid, salt
0.045-0.065 parts of allithiamine element, 0.035-0.045 parts of puridoxine hydrochloride and 0.025-0.045 parts of cobalamin.
The minerals include following material component: 0.02-0.025 parts of calcium monohydrogen phosphate, 0.02-0.03 parts of tricalcium phosphate,
0.06-0.08 parts of magnesium chloride, 0.065-0.095 parts of ferric pyrophosphate, 0.035-0.065 parts of zinc oxide, sodium chloride 0.015-0.025
Part, 0.045-0.065 parts of potassium chloride, 0.04-0.06 parts of potassium iodide, 0.01-0.02 parts of manganese sulfate and sodium selenite 0.01-0.02
Part.
Above-mentioned technical proposal of the invention is understood in order to clearer, below by way of specific example to above-mentioned side of the invention
Case is described in detail.
Embodiment one
A kind of functional beverage can be relieved vision and physical fatigue, this can be relieved the functional drink of vision and physical fatigue
Material is made of the raw material of following mass fraction:
It is wolfberry fruit extract 7g, mint extract 3g, cornel extractive 1g, tea tree purple bud anthocyanidin 10g, lactose 75g, dense
Contracting lactalbumin 32g, caffeine 0.08g, galactooligosaccharide 14g, maca 0.2g, inositol 19g, linoleic acid 2.8g, citric acid
0.1g, essence 0.1g, alpha-linolenic acid 0.3g, sodium citrate 0.1g, sodium benzoate 0.1g, caseinhydrolysate 17.5g, lemon yellow
0.1g, docosahexaenoic acid 10g, zinc citrate 0.04g, casein phosphopeptide 2g, lecithin 25g, cycloheptaamylose
0.01g, regulator 0.3g, antioxidant 0.25g, amino acid 4g, nucleotide 0.25g, vitamin combination 1.562g, minerals
0.32g and water 1500g.
Wherein, the regulator includes following material component: sodium tripolyphosphate 0.05g, Citric Acid Mono 0.2g and alginic acid
Propylene glycol ester 0.05g.
The antioxidant includes following material component: lutein 0.05g, D-araboascorbic acid sodium 0.15g, superoxides
Mutase 0.02g, catalase 0.01g and pyruvic acid 0.02g.
The amino acid includes following material component: taurine 1g, creatine 0.4g, leucine 0.4g, glycine 0.3g, a left side
Revolve carnitine 0.4g, tyrosine 0.2g, lysine 0.6g, aspartic acid 0.3g, theanine 0.2g and glutamine 0.2g.
The nucleotide includes following material component: 5 ' adenosine monophosphate 0.05g, 5 ' inosine acid disodium 0.05g, 5 ' guanosines
Acid disodium 0.05g, 5 ' the uridine monophosphate disodium cytidine acid disodium of 0.05g and 5 ' 0.05g.
The vitamin combination includes following material component: choline chloride 0.015g, L sodium ascorbate 0.055g, vinegar
Sour retinyl ester 0.015g, D calcium pantothenate 0.025g, dl- alpha-tocopherol 0.025g, Vitamin D3 0.035g, phytondione
0.025g and B race composition 1.367g.
B race composition includes following material component: riboflavin 0.065g, niacinamide 0.025g, D-Biotin
0.012g, folic acid 0.015g, niacin 0.045g, pantothenic acid 1.1g, thiamine hydrochloride 0.045g, puridoxine hydrochloride 0.035g and cobalt amine
Plain 0.025g.
The minerals include following material component: calcium monohydrogen phosphate 0.02g, tricalcium phosphate 0.02g, magnesium chloride 0.06g, coke
Ferric phosphate 0.065g, zinc oxide 0.035g, sodium chloride 0.015g, potassium chloride 0.045g, potassium iodide 0.04g, manganese sulfate 0.01g and
Sodium selenite 0.01g.
This can be relieved the preparation of the functional beverage of vision and physical fatigue, comprising the following steps:
According to above-mentioned mass fraction, weigh it is described can be relieved the functional beverage of vision and physical fatigue needed for raw material, and
During weighing, all raw materials in addition to the water are injected in same container, raw material is promoted to be mixed, formed preliminary
Mixture;
The initial mixture is continuously stirred, the raw material is sufficiently mixed, formation is sufficiently mixed object;
Sieving screening is carried out to the object that is sufficiently mixed by preconfigured screening machine, promotes described to be sufficiently mixed object
State is pulverulent mixture;
By preconfigured apparatus for separating metals, postsearch screening is carried out to the object that is sufficiently mixed after sieving screening, is formed super
Finely powdered mixt, and obtained superfine powdery mixture is put into storage box store it is spare;
The water handle by preconfigured low-frequency resonance instrument spare;
The superfine powdery mixture and the low-frequency resonance water are sufficiently mixed by preset proportion in advance, stirred
It is even that preliminary mixed liquor is made;
The preliminary mixed liquor is successively centrifuged at a high speed, homogeneous, sterilization treatment, homogeneous mixed liquor is made;
It is handled the homogeneous mixed liquor to obtain drinks by preconfigured low-frequency resonance instrument;
The drinks finished product sealing obtained is filling.
Embodiment two
A kind of functional beverage can be relieved vision and physical fatigue, this can be relieved the functional drink of vision and physical fatigue
Material is made of the raw material of following mass fraction:
Wolfberry fruit extract 11g, mint extract 3.5g, cornel extractive 3g, tea tree purple bud anthocyanidin 14g, lactose
100g, whey protein concentrate 46g, caffeine 0.1g, galactooligosaccharide 19g, maca 0.8g, inositol 19.5g, linoleic acid 2.83g,
Citric acid 0.3g, essence 0.15g, alpha-linolenic acid 0.385g, sodium citrate 0.2g, sodium benzoate 0.2g, caseinhydrolysate 18g,
Lemon yellow 0.15g, docosahexaenoic acid 20g, zinc citrate 0.045g, casein phosphopeptide 2.5g, lecithin 30g, β-ring
Shape dextrin 0.015g, regulator 0.43g, antioxidant 0.41g, amino acid 5.6g, nucleotide 0.325g, vitamin combination
2.303g, minerals 0.398g and water 3000g.
Wherein, the regulator includes following material component: sodium tripolyphosphate 0.065g, Citric Acid Mono 0.3g and alginic acid
Propylene glycol ester 0.065g.
The antioxidant includes following material component: lutein 0.15g, D-araboascorbic acid sodium 0.18g, superoxides
Mutase 0.03g, catalase 0.02g and pyruvic acid 0.03g.
The amino acid includes following material component: taurine 1.1g, creatine 0.8g, leucine 0.6g, glycine 0.5g,
L-carnitine 0.6g, tyrosine 0.3g, lysine 0.7g, aspartic acid 0.4g, theanine 0.3g and glutamine 0.3g.
The nucleotide includes following material component: 5 ' adenosine monophosphate 0.065g, 5 ' inosine acid disodium 0.065g, 5 ' birds
Thuja acid disodium 0.065g, 5 ' the uridine monophosphate disodium cytidine acid disodium of 0.065g and 5 ' 0.065g.
The vitamin combination includes following material component: choline chloride 0.02g, L sodium ascorbate 0.07g, acetic acid
Retinyl ester 0.02g, D calcium pantothenate 0.03g, dl- alpha-tocopherol 0.035g, Vitamin D3 0.04g, phytondione 0.035g and B
Race composition 2.053g.
B race composition includes following material component: riboflavin 0.08g, niacinamide 0.05g, D-Biotin 0.018g,
Folic acid 0.02g, niacin 0.055g, pantothenic acid 1.7g, thiamine hydrochloride 0.055g, puridoxine hydrochloride 0.04g and cobalamin 0.035g.
The minerals include following material component: calcium monohydrogen phosphate 0.023g, tricalcium phosphate 0.025g, magnesium chloride 0.07g,
Ferric pyrophosphate 0.08g, zinc oxide 0.05g, sodium chloride 0.02g, potassium chloride 0.05g, potassium iodide 0.05g, manganese sulfate 0.015g and
Sodium selenite 0.015g.
This can be relieved the preparation of the functional beverage of vision and physical fatigue, comprising the following steps:
According to above-mentioned mass fraction, weigh it is described can be relieved the functional beverage of vision and physical fatigue needed for raw material, and
During weighing, all raw materials in addition to the water are injected in same container, raw material is promoted to be mixed, formed preliminary
Mixture;
The initial mixture is continuously stirred, the raw material is sufficiently mixed, formation is sufficiently mixed object;
Sieving screening is carried out to the object that is sufficiently mixed by preconfigured screening machine, promotes described to be sufficiently mixed object
State is pulverulent mixture;
By preconfigured apparatus for separating metals, postsearch screening is carried out to the object that is sufficiently mixed after sieving screening, is formed super
Finely powdered mixt, and obtained superfine powdery mixture is put into storage box store it is spare;
The water handle by preconfigured low-frequency resonance instrument spare;
The superfine powdery mixture and the low-frequency resonance water are sufficiently mixed by preset proportion in advance, stirred
It is even that preliminary mixed liquor is made;
The preliminary mixed liquor is successively centrifuged at a high speed, homogeneous, sterilization treatment, homogeneous mixed liquor is made;
It is handled the homogeneous mixed liquor to obtain drinks by preconfigured low-frequency resonance instrument;
The drinks finished product sealing obtained is filling.
Embodiment three
A kind of functional beverage can be relieved vision and physical fatigue, this can be relieved the functional drink of vision and physical fatigue
Material is made of the raw material of following mass fraction:
Wolfberry fruit extract 15g, mint extract 4g, cornel extractive 5g, tea tree purple bud anthocyanidin 17g, lactose 125g,
Whey protein concentrate 55g, caffeine 0.12g, galactooligosaccharide 26g, maca 1.5g, inositol 20g, linoleic acid 2.86g, citric acid
0.5g, essence 0.2g, alpha-linolenic acid 0.39g, sodium citrate 0.3g, sodium benzoate 0.3g, caseinhydrolysate 18.5g, lemon yellow
0.2g, docosahexaenoic acid 30g, zinc citrate 0.05g, casein phosphopeptide 3g, lecithin 35g, cycloheptaamylose
0.02g, regulator 0.56g, antioxidant 0.58g, amino acid 7.2g, nucleotide 0.4g, vitamin combination 3.155g, mineral
Matter 0.485g and water 4500g.
Wherein, the regulator includes following material component: sodium tripolyphosphate 0.08g, Citric Acid Mono 0.4g and alginic acid
Propylene glycol ester 0.08g.
The antioxidant includes following material component: lutein 0.25g, D-araboascorbic acid sodium 0.22g, superoxides
Mutase 0.04g, catalase 0.03g and pyruvic acid 0.04g.
The amino acid includes following material component: taurine 1.2g, creatine 1.2g, leucine 0.8g, glycine 0.6g,
L-carnitine 0.8g, tyrosine 0.4g, lysine 0.8g, aspartic acid 0.6g, theanine 0.4g and glutamine 0.4g.
The nucleotide includes following material component: 5 ' adenosine monophosphate 0.08g, 5 ' inosine acid disodium 0.08g, 5 ' guanosines
Acid disodium 0.08g, 5 ' the uridine monophosphate disodium cytidine acid disodium of 0.08g and 5 ' 0.08g.
The vitamin combination includes following material component: choline chloride 0.025g, L sodium ascorbate 0.085g, vinegar
Sour retinyl ester 0.025g, D calcium pantothenate 0.035g, dl- alpha-tocopherol 0.045g, Vitamin D3 0.045g, phytondione
0.045g and B race composition 2.85g.
B race composition includes following material component: riboflavin 0.095g, niacinamide -0.085g, D-Biotin
0.025g, folic acid 0.025g, niacin 0.065g, pantothenic acid 2.4g, thiamine hydrochloride 0.065g, puridoxine hydrochloride 0.045g and cobalt amine
Plain 0.045g.
The minerals include following material component: calcium monohydrogen phosphate 0.025g, tricalcium phosphate 0.03g, magnesium chloride 0.08g,
Ferric pyrophosphate 0.095g, zinc oxide 0.065g, sodium chloride 0.025g, potassium chloride 0.065g, potassium iodide 0.06g, manganese sulfate 0.02g
With sodium selenite 0.02g.
This can be relieved the preparation of the functional beverage of vision and physical fatigue, comprising the following steps:
According to above-mentioned mass fraction, weigh it is described can be relieved the functional beverage of vision and physical fatigue needed for raw material, and
During weighing, all raw materials in addition to the water are injected in same container, raw material is promoted to be mixed, formed preliminary
Mixture;
The initial mixture is continuously stirred, the raw material is sufficiently mixed, formation is sufficiently mixed object;
Sieving screening is carried out to the object that is sufficiently mixed by preconfigured screening machine, promotes described to be sufficiently mixed object
State is pulverulent mixture;
By preconfigured apparatus for separating metals, postsearch screening is carried out to the object that is sufficiently mixed after sieving screening, is formed super
Finely powdered mixt, and obtained superfine powdery mixture is put into storage box store it is spare;
The water handle by preconfigured low-frequency resonance instrument spare;
The superfine powdery mixture and the low-frequency resonance water are sufficiently mixed by preset proportion in advance, stirred
It is even that preliminary mixed liquor is made;
The preliminary mixed liquor is successively centrifuged at a high speed, homogeneous, sterilization treatment, homogeneous mixed liquor is made;
It is handled the homogeneous mixed liquor to obtain drinks by preconfigured low-frequency resonance instrument;
The drinks finished product sealing obtained is filling.
In order to facilitate above-mentioned technical proposal of the invention is understood, below in conjunction with attached drawing to the process of above scheme of the invention
It is described in detail, specific as follows:
As shown in Figure 1, in the actual production process, this can be relieved the preparation of the functional beverage of vision and physical fatigue,
The following steps are included:
Step S101 weighs the functional beverage institute that can be relieved vision and physical fatigue according to above-mentioned mass fraction
Raw material is needed, and during weighing, all raw materials in addition to the water are injected in same container, raw material is promoted to be mixed
It closes, forms initial mixture;
Step S103 continuously stirs the initial mixture, is sufficiently mixed the raw material, formation is sufficiently mixed
Object;
Step S105 carries out sieving screening to the object that is sufficiently mixed by preconfigured screening machine, promotes described fill
The state for dividing mixture is pulverulent mixture;
Step S107 carries out secondary sieve to the object that is sufficiently mixed after sieving screening by preconfigured apparatus for separating metals
Choosing forms superfine powdery mixture, and obtained superfine powdery mixture is put into storage box store it is spare;
Step S109 handle to the water spare by preconfigured low-frequency resonance instrument;
Step S111, it is by preset proportion in advance that the superfine powdery mixture and low-frequency resonance water progress is sufficiently mixed
It closes, stir evenly preliminary mixed liquor is made;
The preliminary mixed liquor is successively centrifuged at a high speed, homogeneous, sterilization treatment by step S113, and homogeneous is made
Mixed liquor;
Step S115 is handled the homogeneous mixed liquor by preconfigured low-frequency resonance instrument to obtain function drink
Material;
Step S117, the drinks finished product sealing obtained is filling.
In one embodiment, the sterilization treatment uses high temperature sterilization, and temperature is 100-110 DEG C, and sterilizing time is
30-35 points kinds.
In order to facilitate above-mentioned technical proposal of the invention is understood, below in conjunction with experimental data to above scheme of the invention
It is described in detail, specific as follows:
Test report:
1, sleep quality is tested:
Experimental subjects: sportsman 20, male.Experimental tool: Pittsburgh Sleep Quality Index (PSQI), the total score of PSQI
Range is 0-21 points, and score is higher, indicates that sleep quality is poorer.Test method: 20 sportsmen are divided into two groups, every group 10 parts points
It Wei not experimental group and control group.1-5 days, without any training, 6-15 days, identical high pressure training, experimental group were arranged daily
Beverage 500g of the present invention is drunk respectively after training and before sleeping, and control group does not drink any beverage.
Table 1, experimental group and control group sleep quality table
Control group M ± SD | Experimental group M ± SD | |
Sleep total score | 9.52±2.16 | 6.95±2.22 |
Consciously sleep matter | 1.36±0.27 | 1.30±0.35 |
Time for falling asleep | 1.92±0.51 | 1.28±0.52 |
Sleeping time | 1.04±0.41 | 0.86±0.26 |
Sleep efficiency | 1.11±0.23 | 1.02±0.30 |
Sleep disturbance | 1.27±0.26 | 1.03±0.20 |
Hypnotic drug | 0.15±0.32 | 0.10±0.40 |
Day function obstacle | 2.16±0.31 | 2.03±0.33 |
Experiment conclusion: as shown in table 1, experimental group sleep quality is substantially better than control group sleep quality.
2, acute toxicity test
Using horn method, healthy mice is chosen, is adapted to environment 5 days, fasting 16 hours, can't help water, just before taking
Trial test is carried out with 20 multiple dose stomach-filling mouse before formula test, mouse is without exception, mouse 40 for selecting weight JJ2sg or so then
(half male and half female) is randomly divided into 5 groups, respectively with 5 times of human dose, 10 times, 20 times, 40 times and 80 times for mouse study dosage
It carries out examination to stay, respectively by the disposably oral stomach-filling of above-mentioned dosage, stomach-filling volume is 0.2mU10g-bw.It is observed continuously after stomach-filling 1 week
Left and right records poisoning manifestations and death condition.
Mouse the acute toxicity tests in 2 beverage of table
Dosage group | Mouse quantity (only) | Poisoning symptom | Death condition |
5 times | 8 | Without poisoning | Without death |
10 times | 8 | Without poisoning | Without death |
20 times | 8 | Without poisoning | Without death |
40 times | 8 | Without poisoning | Without death |
80 times | 8 | Without poisoning | Without death |
3, genetic toxicity test
Mouse 40 (half male and half female) of weight 2sg or so are taken, beverage Lutein concentration is 10, the 50 of human intaking amount
And 100 times of conduct low dose groups, middle dose group and high dose group are tested, and are in addition also provided with negative control group (using steaming
Distilled water) and positive controls (using cyclophosphamide, 40mg/kg-bw).Daily stomach-filling 1 time, continuous 2 days, last stomach-filling 6 hours
After take breastbone make sample, carry out diagosis.
Influence of 3 beverage of table to Micronuclei In The Mouse Bone Marrow incidence
As can be seen from Table 3, test group animal is under each test dose, polychromatic erythrocyte (PCE) Rate of Appearance Micronuclei,
There are no significant for the difference of PCE/RBC and negative control group, and positive controls show strong mutagenesis, tests explanation
The beverage is without mutagenesis.
4, hematological indices
When acquiring serum, a part of blood is contained in the glass tube for adding anti-coagulants, another part is placed in no anti-coagulants glass
To rigid in glass pipe.Anticoagulation is taken to measure the routine hematology index in test latter stage in blood analyser: hemoglobin, red thin
Born of the same parents, leucocyte, as a result as follows:
4 rat blood index determining result (X ± S, g) of table
As can be seen from Table 4, high, medium and low three groups of mouse blood indexs of drinks are compared with the control group without aobvious
It writes sex differernce (P > 0.05), shows each dosage knob to the change without exception of the hematological indices of mouse.Because red thin in blood
Born of the same parents, leucocyte and hemoglobin and blood plasma are to form body metabolism and the indispensable blood circulation system of function point analysis
It unites, pathological change occurs for any index components in blood, can all influence the histoorgan of whole body.Ridge this can be by big
Three indexs of the red blood cell in mouse blood, leucocyte and hemoglobin are analyzed, and the health status of body can be understood.On
It states experimental result and measures that hematological indices are normal, illustrate that the beverage does not cause fiery rat tissue or Organic variation.
In conclusion by means of above-mentioned technical proposal of the invention, it is provided by the invention to can be relieved vision and physical fatigue
Functional beverage simultaneously using each raw material effective component, so that it is complemented each other, greatly improve the beverage alleviate physical fatigue
And the effect of asthenopia, while having both excellent health properties.The dispersion performance of each component is substantially increased, and is effectively reduced
The wherein loss of nutritional ingredient keeps the beverage product stability being prepared into high, is conducive to large-scale industrial production.The present invention mentions
Above-mentioned various functional components are scientifically incorporated products by the functional beverage that can be relieved vision and physical fatigue supplied, these
Ingredient cooperates, and synergistic effect can promote human metabolism, absorbs and decomposes sugar, supplements a large amount of energy rapidly
Substance, and nervous function is adjusted, so that acquirement refreshes the mind, regains one's strength of body, antifatigue superior efficacy.Therefore, people exists
When physiologic fatigability, energy i (in vivo) material want, energetic supersession is insufficient or there are obstacle, drinks the drinks, Ke Yichong
Divide supplement energy, quickly eliminates fatigue, inspire enthusiasm, raising working efficiency and quality of life.It is provided by the invention to can be relieved view
Drink before the functional beverage of feel and physical fatigue is drunk after a large amount of movements perhaps heavy physical labour or next day match is slept
With can be effectively relieved fatigue, improve sleep quality;Spleen benefiting and stimulating the appetite helps digest;It can be improved heart blood supply function simultaneously;
Each raw material mutually acts synergistically, and promotes antisecosis.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention
Within mind and principle, any modification, equivalent replacement, improvement and so on be should all be included in the protection scope of the present invention.
Claims (10)
1. a kind of functional beverage that can be relieved vision and physical fatigue, which is characterized in that this can be relieved vision and physical fatigue
Functional beverage be made of the raw material of following mass fraction:
7-15 parts of wolfberry fruit extract, 3-4 parts of mint extract, 1-5 parts of cornel extractive, 10-17 parts of tea tree purple bud anthocyanidin,
75-125 parts of lactose, 32-55 parts of whey protein concentrate, 0.08-0.12 parts of caffeine, 14-26 parts of galactooligosaccharide, maca 0.2-
1.5 parts, 19-20 parts of inositol, 2.8-2.86 parts of linoleic acid, 0.1-0.5 parts of citric acid, 0.1-0.2 parts of essence, alpha-linolenic acid
0.38-0.39 parts, 0.1-0.3 parts of sodium citrate, 0.1-0.3 parts of sodium benzoate, 17.5-18.5 parts of caseinhydrolysate, lemon yellow
0.1-0.2 parts, 10-30 parts of docosahexaenoic acid, 0.04-0.05 parts of zinc citrate, 2-3 parts of casein phosphopeptide, lecithin
25-35 parts, 0.01-0.02 parts of cycloheptaamylose, 0.3-0.56 parts of regulator, 0.25-0.58 parts of antioxidant, amino acid 4-
7.2 parts, 0.25-0.4 parts of nucleotide, 1.562-3.155 parts of vitamin combination, 0.32-0.485 parts of minerals and water 1500-
4500 parts.
2. the functional beverage according to claim 1 that can be relieved vision and physical fatigue, which is characterized in that the adjusting
Agent includes following material component: 0.05-0.08 parts of sodium tripolyphosphate, 0.2-0.4 parts of Citric Acid Mono and propylene glycol alginate
0.05-0.08 parts.
3. the functional beverage according to claim 2 that can be relieved vision and physical fatigue, which is characterized in that the antioxygen
Agent includes following material component: 0.05-0.25 parts of lutein, 0.15-0.22 parts of D-araboascorbic acid sodium, superoxide dismutase
0.02-0.04 parts of enzyme, 0.01-0.03 parts of catalase and 0.02-0.04 parts of pyruvic acid.
4. the functional beverage according to claim 3 that can be relieved vision and physical fatigue, which is characterized in that the amino
Acid includes following material component: 1-1.2 parts of taurine, 0.4-1.2 parts of creatine, 0.4-0.8 parts of leucine, glycine 0.3-0.6
Part, 0.4-0.8 parts of L-carnitine, 0.2-0.4 parts of tyrosine, 0.6-0.8 parts of lysine, 0.3-0.6 parts of aspartic acid, theanine
0.2-0.4 parts and glutamine 0.2-0.4 parts.
5. the functional beverage according to claim 4 that can be relieved vision and physical fatigue, which is characterized in that the nucleosides
Acid includes following material component: 5 ' 0.05-0.08 parts of adenosine monophosphate, 0.05-0.08 parts of 5 ' inosine acid disodium, 5 ' guanylic acids two
0.05-0.08 parts of 0.05-0.08 parts of sodium, 0.05-0.08 parts of 5 ' uridine monophosphate disodium and 5 ' cytidine acid disodium.
6. the functional beverage according to claim 5 that can be relieved vision and physical fatigue, which is characterized in that the dimension life
Promotor composition includes following material component: 0.015-0.025 parts of choline chloride, 0.055-0.085 parts of L sodium ascorbate, acetic acid
0.015-0.025 parts of retinyl ester, 0.025-0.035 parts of D calcium pantothenate, 0.025-0.045 parts of dl- alpha-tocopherol, Vitamin D3
Composition 1.367-2.85 parts of 0.035-0.045 parts, 0.025-0.045 parts of phytondione and B race.
7. the functional beverage according to claim 6 that can be relieved vision and physical fatigue, which is characterized in that the B race
Composition includes following material component: 0.065-0.095 parts of riboflavin, 0.025-0.085 parts of niacinamide, D-Biotin 0.012-
0.025 part, 0.015-0.025 parts of folic acid, 0.045-0.065 parts of niacin, 1.1-2.4 parts of pantothenic acid, thiamine hydrochloride 0.045-
0.065 part, 0.035-0.045 parts of puridoxine hydrochloride and 0.025-0.045 parts of cobalamin.
8. the functional beverage according to claim 7 that can be relieved vision and physical fatigue, which is characterized in that the mineral
Matter includes following material component: 0.02-0.025 parts of calcium monohydrogen phosphate, 0.02-0.03 parts of tricalcium phosphate, magnesium chloride 0.06-0.08
Part, 0.065-0.095 parts of ferric pyrophosphate, 0.035-0.065 parts of zinc oxide, 0.015-0.025 parts of sodium chloride, potassium chloride 0.045-
0.065 part, 0.04-0.06 parts of potassium iodide, 0.01-0.02 parts of manganese sulfate and 0.01-0.02 parts of sodium selenite.
9. a kind of preparation method for the functional beverage that can be relieved vision and physical fatigue, which is characterized in that be used for claim 8
The preparation of the functional beverage that can be relieved vision and physical fatigue, comprising the following steps:
According to above-mentioned mass fraction, weigh it is described can be relieved the functional beverage of vision and physical fatigue needed for raw material, and claiming
During taking, all raw materials in addition to the water are injected in same container, raw material is promoted to be mixed, forms preliminary mixing
Object;
The initial mixture is continuously stirred, the raw material is sufficiently mixed, formation is sufficiently mixed object;
Sieving screening is carried out to the object that is sufficiently mixed by preconfigured screening machine, promotes the state for being sufficiently mixed object
For pulverulent mixture;
By preconfigured apparatus for separating metals, postsearch screening is carried out to the object that is sufficiently mixed after sieving screening, forms superfine powder
Shape mixture, and obtained superfine powdery mixture is put into storage box store it is spare;
The water handle by preconfigured low-frequency resonance instrument spare;
The superfine powdery mixture and the low-frequency resonance water are sufficiently mixed by preset proportion in advance, the system of stirring evenly
Obtain preliminary mixed liquor;
The preliminary mixed liquor is successively centrifuged at a high speed, homogeneous, sterilization treatment, homogeneous mixed liquor is made;
It is handled the homogeneous mixed liquor to obtain drinks by preconfigured low-frequency resonance instrument;
The drinks finished product sealing obtained is filling.
10. the preparation method of the functional beverage according to claim 9 that can be relieved vision and physical fatigue, feature exist
In the sterilization treatment uses high temperature sterilization, and temperature is 100-110 DEG C, and sterilizing time is 30-35 points kinds.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811554191.0A CN109527313A (en) | 2018-12-18 | 2018-12-18 | A kind of functional beverage and preparation method thereof can be relieved vision and physical fatigue |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811554191.0A CN109527313A (en) | 2018-12-18 | 2018-12-18 | A kind of functional beverage and preparation method thereof can be relieved vision and physical fatigue |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109527313A true CN109527313A (en) | 2019-03-29 |
Family
ID=65853615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811554191.0A Pending CN109527313A (en) | 2018-12-18 | 2018-12-18 | A kind of functional beverage and preparation method thereof can be relieved vision and physical fatigue |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109527313A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021041293A1 (en) * | 2019-08-23 | 2021-03-04 | The Coca-Cola Company | Stable creatine beverages |
CN114096165A (en) * | 2020-04-10 | 2022-02-25 | 上海利统生化制品有限公司 | Edible composition for relieving visual fatigue |
CN114451506A (en) * | 2022-02-22 | 2022-05-10 | 韦东 | Functional composite beverage formula and production process thereof |
CN117337988A (en) * | 2023-11-30 | 2024-01-05 | 吉林浩泰健康产业发展股份有限公司 | Electrolyte solid beverage and preparation method thereof |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101036515A (en) * | 2006-03-13 | 2007-09-19 | 中食肽灵(北京)生物科技有限公司 | Physical recovery healthy food and preparation process thereof |
CN101803633A (en) * | 2010-04-23 | 2010-08-18 | 杭州宏胜饮料集团有限公司 | Health care milk beverage for relieving visual fatigue and preparation method thereof |
CN102150724A (en) * | 2011-03-30 | 2011-08-17 | 姜天安 | Functional mixture for refreshing and remitting physical fatigue and visual fatigue and application thereof |
CN102763878A (en) * | 2012-07-25 | 2012-11-07 | 北京中科健宇生物科技有限公司 | Functional health maca drink and production method thereof |
CN102960810A (en) * | 2012-12-05 | 2013-03-13 | 上海普维健康食品有限公司 | Maca beverage |
CN103211259A (en) * | 2013-04-22 | 2013-07-24 | 河南省淼雨饮品股份有限公司 | Anti-fatigue vitamin health care beverage and preparation method thereof |
CN104223119A (en) * | 2014-07-30 | 2014-12-24 | 理想科技集团有限公司 | Lepidium meyenii walp protein nutritional supplement for relieving physical fatigue and preparation method of lepidium meyenii walp protein nutritional supplement |
CN107252114A (en) * | 2017-07-01 | 2017-10-17 | 马南行 | A kind of composition of strengthen immunity anti-aging and preparation method thereof |
CN107439890A (en) * | 2017-08-22 | 2017-12-08 | 王海军 | A kind of anti-fatigue solid beverage and preparation method thereof |
CN107811176A (en) * | 2017-11-07 | 2018-03-20 | 张永刚 | Horse base certain kind of berries healthy functions beverage and preparation method |
CN107821602A (en) * | 2017-10-30 | 2018-03-23 | 诺和生物技术(天津)有限公司 | Nutrient formulation powder that a kind of suitable muscle decay crowd eats and preparation method thereof |
CN108174921A (en) * | 2018-02-08 | 2018-06-19 | 呼伦贝尔双娃乳业有限公司 | A kind of organic babies ' formula milk powder |
CN108450962A (en) * | 2018-02-27 | 2018-08-28 | 湖北圣峰药业有限公司 | A kind of solid beverage and preparation method thereof for Woman health |
CN108606199A (en) * | 2018-03-27 | 2018-10-02 | 佛山市体视能饮料有限公司 | A kind of functional beverage and preparation method thereof for alleviating muscle power and asthenopia |
CN108651634A (en) * | 2018-04-24 | 2018-10-16 | 宁波米拉山国际贸易有限公司 | A kind of formula milk and preparation method thereof being suitble to 0 to 6 months babies |
-
2018
- 2018-12-18 CN CN201811554191.0A patent/CN109527313A/en active Pending
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101036515A (en) * | 2006-03-13 | 2007-09-19 | 中食肽灵(北京)生物科技有限公司 | Physical recovery healthy food and preparation process thereof |
CN101803633A (en) * | 2010-04-23 | 2010-08-18 | 杭州宏胜饮料集团有限公司 | Health care milk beverage for relieving visual fatigue and preparation method thereof |
CN102150724A (en) * | 2011-03-30 | 2011-08-17 | 姜天安 | Functional mixture for refreshing and remitting physical fatigue and visual fatigue and application thereof |
CN102763878A (en) * | 2012-07-25 | 2012-11-07 | 北京中科健宇生物科技有限公司 | Functional health maca drink and production method thereof |
CN102960810A (en) * | 2012-12-05 | 2013-03-13 | 上海普维健康食品有限公司 | Maca beverage |
CN103211259A (en) * | 2013-04-22 | 2013-07-24 | 河南省淼雨饮品股份有限公司 | Anti-fatigue vitamin health care beverage and preparation method thereof |
CN104223119A (en) * | 2014-07-30 | 2014-12-24 | 理想科技集团有限公司 | Lepidium meyenii walp protein nutritional supplement for relieving physical fatigue and preparation method of lepidium meyenii walp protein nutritional supplement |
CN107252114A (en) * | 2017-07-01 | 2017-10-17 | 马南行 | A kind of composition of strengthen immunity anti-aging and preparation method thereof |
CN107439890A (en) * | 2017-08-22 | 2017-12-08 | 王海军 | A kind of anti-fatigue solid beverage and preparation method thereof |
CN107821602A (en) * | 2017-10-30 | 2018-03-23 | 诺和生物技术(天津)有限公司 | Nutrient formulation powder that a kind of suitable muscle decay crowd eats and preparation method thereof |
CN107811176A (en) * | 2017-11-07 | 2018-03-20 | 张永刚 | Horse base certain kind of berries healthy functions beverage and preparation method |
CN108174921A (en) * | 2018-02-08 | 2018-06-19 | 呼伦贝尔双娃乳业有限公司 | A kind of organic babies ' formula milk powder |
CN108450962A (en) * | 2018-02-27 | 2018-08-28 | 湖北圣峰药业有限公司 | A kind of solid beverage and preparation method thereof for Woman health |
CN108606199A (en) * | 2018-03-27 | 2018-10-02 | 佛山市体视能饮料有限公司 | A kind of functional beverage and preparation method thereof for alleviating muscle power and asthenopia |
CN108651634A (en) * | 2018-04-24 | 2018-10-16 | 宁波米拉山国际贸易有限公司 | A kind of formula milk and preparation method thereof being suitble to 0 to 6 months babies |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021041293A1 (en) * | 2019-08-23 | 2021-03-04 | The Coca-Cola Company | Stable creatine beverages |
CN114096165A (en) * | 2020-04-10 | 2022-02-25 | 上海利统生化制品有限公司 | Edible composition for relieving visual fatigue |
CN114096165B (en) * | 2020-04-10 | 2023-09-19 | 上海利统生化制品有限公司 | Edible composition for relieving asthenopia |
CN114451506A (en) * | 2022-02-22 | 2022-05-10 | 韦东 | Functional composite beverage formula and production process thereof |
CN117337988A (en) * | 2023-11-30 | 2024-01-05 | 吉林浩泰健康产业发展股份有限公司 | Electrolyte solid beverage and preparation method thereof |
CN117337988B (en) * | 2023-11-30 | 2024-03-12 | 吉林浩泰健康产业发展股份有限公司 | Electrolyte solid beverage and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2255818B1 (en) | Oral or enteral composition useful for recovery of physical functions | |
CN100355420C (en) | Leucine-enriched nutritional compositions | |
CN109527313A (en) | A kind of functional beverage and preparation method thereof can be relieved vision and physical fatigue | |
CN107495343A (en) | A kind of generation meal milk shake and preparation method thereof | |
CN103211259B (en) | Anti-fatigue vitamin health care beverage and preparation method thereof | |
CN104509919A (en) | Functional nutrient beverage | |
JP2014501530A (en) | Nutritional supplements containing calcium beta-hydroxy-betamethylbutyrate and conjugated linoleic acid | |
CN108651998A (en) | It is a kind of have relieve fatigue PURE WHEY of function and preparation method thereof | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN111802476A (en) | Milk powder for improving sleep quality of children and preparation method thereof | |
CN107048137A (en) | It is a kind of suitable for low-phosphorus whey albumen powder of Patients with Chronic Renal Disease and preparation method thereof | |
CN112137095A (en) | Sports nutritional composition and preparation method thereof | |
CN101842094A (en) | Anti-fatigue agent comprising amino acid composition | |
CN102160664A (en) | Nutritious drink for children | |
EP1549158B1 (en) | Infant formula containing nucleotides | |
CN108651634A (en) | A kind of formula milk and preparation method thereof being suitble to 0 to 6 months babies | |
CN108013299A (en) | Supplement physical efficiency beverage | |
CN108606269A (en) | A kind of sports type nutritional supplement and preparation method thereof | |
CN106418067A (en) | Health beverage capable of replenishing physical power and relieving fatigue | |
CN110973645A (en) | Protein powder with brain nerve nutrition function | |
JP2017203018A (en) | Hair growing method by activation in which nutritional drinking water and nutrient of animal/vegetable foods are given to in vivo cells while applying mixed hair-restoring liquid to scalp | |
CN110584120A (en) | Bone health composition | |
CN102579956B (en) | Medicament composition and application thereof | |
CN107772458A (en) | A kind of formula powder for hyperhomocysteinemiainjury and preparation method thereof | |
CN107889889A (en) | A kind of formula for the Astaxanthin In Haematococcus Pluvialis milk powder for contributing to recovery of parturient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |